AtriCure, Inc. Earnings Per Share (Basic)
AtriCure, Inc. (ATRC) reported Earnings Per Share (Basic) of $0.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-27
- AtriCure, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.18.
- AtriCure, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.00.
- AtriCure, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.04.
- AtriCure, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.01.
- AtriCure, Inc. earnings per share, basic for fiscal 2025 was -$0.24.
- AtriCure, Inc. earnings per share, basic for fiscal 2024 was -$0.95.
- AtriCure, Inc. earnings per share, basic for fiscal 2023 was -$0.66.
- AtriCure, Inc. earnings per share, basic for fiscal 2022 was -$1.02, a 191.89% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.18 10-Q · filed 2026-07-27 | $0.19 10-Q · filed 2026-07-27 | $0.22 derived: net income ÷ weighted average shares · filed 2026-07-27 | $0.22 derived: net income ÷ weighted average shares · filed 2026-07-27 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.04 derived: net income ÷ weighted average shares · filed 2026-05-06 | $0.03 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-07-27 |
| 2025-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2026-04-06 | $0.03 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-07-27 | -$0.24 10-K · filed 2026-02-19 |
| 2025-09-30 | -$0.01 10-Q · filed 2025-10-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-07-27 | -$0.28 10-Q · filed 2025-10-30 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-07-27 |
| 2025-06-30 | -$0.13 10-Q · filed 2026-07-27 | -$0.27 10-Q · filed 2026-07-27 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-07-27 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-07-27 |
| 2025-03-31 | -$0.14 10-Q · filed 2026-05-06 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-05-06 |
| 2024-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.95 10-K · filed 2026-02-19 |
| 2024-09-30 | -$0.17 10-Q · filed 2025-10-30 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-10-30 | -$0.62 10-Q · filed 2025-10-30 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2024-06-30 | -$0.17 10-Q · filed 2025-07-30 | -$0.45 10-Q · filed 2025-07-30 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2024-03-31 | -$0.28 10-Q · filed 2025-04-30 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2023-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.66 10-K · filed 2026-02-19 |
| 2023-09-30 | -$0.20 10-Q · filed 2024-10-30 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-10-30 | -$0.45 10-Q · filed 2024-10-30 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2023-06-30 | -$0.11 10-Q · filed 2024-07-31 | -$0.25 10-Q · filed 2024-07-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2023-03-31 | -$0.14 10-Q · filed 2024-05-02 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2022-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$1.02 10-K · filed 2025-02-14 |
| 2022-09-30 | -$0.27 10-Q · filed 2023-11-02 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$0.93 10-Q · filed 2023-11-02 | -$1.23 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2022-06-30 | -$0.32 10-Q · filed 2023-07-26 | -$0.66 10-Q · filed 2023-07-26 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.17 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2022-03-31 | -$0.33 10-Q · filed 2023-05-03 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.50 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.15 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2021-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.84 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.48 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.11 10-K · filed 2024-02-16 |
| 2021-09-30 | $2.15 10-Q · filed 2022-11-02 | $1.79 derived: net income ÷ weighted average shares · filed 2022-11-02 | $1.42 10-Q · filed 2022-11-02 | $1.01 derived: net income ÷ weighted average shares · filed 2023-02-22 |
| 2021-06-30 | -$0.36 10-Q · filed 2022-08-03 | -$0.74 10-Q · filed 2022-08-03 | -$1.16 derived: net income ÷ weighted average shares · filed 2023-02-22 | -$1.27 derived: net income ÷ weighted average shares · filed 2023-02-22 |
| 2021-03-31 | -$0.38 10-Q · filed 2022-05-04 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-02-22 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-02-22 | |
| 2020-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2023-02-22 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-02-22 | -$1.14 10-K · filed 2023-02-22 | |
| 2020-09-30 | -$0.11 10-Q · filed 2021-11-04 | -$0.71 10-Q · filed 2021-11-04 | ||
| 2019-12-31 | -$0.94 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |